Journal of Cardiac and Pulmonary Rehabilitation
Open Access

Chronic obstructive pulmonary disease (COPD) is a heterogeneous problem described by small and large aviation dysfunction and destruction of the lung parenchyma and vasculature in profoundly factor combinations [1]. Breathlessness and exercise intolerance are the most well-known side effects in COPD and both advancement perseveringly through the regular history of disease and might be joined by the improvement of chronic hypoxaemia. Long haul oxygen treatment (LTOT) in resting hypoxaemic COPD patients has physiological advantages (for instance, inversion of polycythemia, further developed practice execution, worked on neurological status, decreased aspiratory hypertension) and along with pneumonic recovery might further develop wellbeing related personal satisfaction (HRQL) [2-5]. Moreover just LTOT and smoking end have been displayed to further develop endurance in patients with COPD.

In a review of patients with extreme COPD treated with LTOT, half didn't take off from the house (MRC dyspnoea grade 5) and 78% were breathless while strolling around at home and performing activities of daily living (ADL). In cutting edge COPD, hypoxaemia for the most part deteriorates during exercise and actuates a transient yet stamped height of pulmonary artery pressure (PAP). This can be basically as high as 20-30mmlHg during a consistent state (40watt) exercise task. Breathing oxygen during exercise produces a small yet critical fall of PAP and pulmonary vascular resistance. 0 Accordingly it is sensible that oxygen ought to be recommended during exercise to patients prescribed LTOT.

The solution of ambulatory oxygen therapy to patients with huge hypoxaemia just during effort is still being talked about. Ambulatory oxygen is characterized as oxygen conveyed by hardware that can be conveyed by most patients. In the UK this is furnished with little oxygen chambers enduring one to three hours at a 2 L/min-1 stream. Other countries, like the USA and Italy, give liquid oxygen in portable strollers that allow for longer periods of autonomy (as long as 10 hours at 2Lmin-1). Both these frameworks are utilized without adequate supporting proof. Nevertheless ambulatory oxygen therapy has broadly been displayed to increment practice execution and to ease practice dyspnoea in patients with COPD. The main mechanism for the effect of oxygen on exercise tolerance has recently been clarified. Recent studies indicate that reduction in hyperinflation plays an important role in the oxygen related relief of dyspnoea. Interestingly, supplemental oxygen generally increases exercise tolerance in patients with only mild to moderate hypoxaemia that is not severe enough to meet guidelines for LTOT.

However, little is known about the effectiveness of ambulatory oxygen therapy when utilized for longer periods notwithstanding fixed oxygen delivery. An endeavor to assess the adequacy of long haul ambulatory oxygen therapy in patients with chronic lung disease on exercise capacity, side effect discernment and other important estimations of progress was as of late made by a systematic review. In this audit, 90 abstracts and 17 full text papers were analyzed however just two preliminaries exploring the impacts of ambulatory oxygen therapy in COPD met the inclusion criteria and indicated that the treatment of COPD patients with ambulatory domiciliary oxygen therapy failed to show any consistent benefit.

There was no unmistakable impact of oxygen therapy on practice limit, dyspnoea, HRQL or lung work one review revealed huge upgrades in minute ventilation and Pa O2 that was not detailed by the other. The oxygen supplementation induced some acute increments in exercise performance, such improvements had little impact on patients ADL. However their patients did not suffer from severe hypoxaemia and would not have met the criteria for LTOT, unlike the patients of the ambulatory oxygen therapy was of more value than placebo in a selected group of COPD patients with COR Pulmonale and resting hypoxaemia.

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163: 1256-1276.

Indexed at, Google Scholar, Crossref

2. Report of British Research Medical Council Working Party (1981) Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complication in chronic bronchitis and emphysema. Lancet 1: 681 -686.

Indexed at

3. Noctumal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 93: 391-398.

Indexed at, Google Scholar, Crossref

4. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: S77-S121.

Indexed at, Google Scholar

5. Weitzenblum E, Oswald M, Apprill M, Ratomaharo J, Kessler R (1991) Evolution of physiological variables in patients with chronic obstructive pulmonary disease before and during long term oxygen therapy. Respiration 58: 126-131.

Indexed at, Google Scholar, Crossref